Furthermore, treatment with IL-23 increased macrophage survival (Fig. 6b), their C. albicans killing capacity (Fig. 6c), and reduced inflammation during infection (Fig. 6d), as seen in macrophages treated with the ferroptosis inhibitor (Fig. 4). Here, IL23A is linked to infection.